PMEL and melanoma: Weekly stimulations of patients' PBMC with the pDC line pulsed either with MelA, GP100, TYR or MAGE-3 peptide led to the massive amplification of specific CD8+ T cells for at least 2 out of 4 melanoma antigens (Figures 5A and 5B).